The strategy that will
guarantee your success!
Our innovative IMF® strategy offers
you an effective therapy approach to functional improvement
following a stroke, spinal cord injury, multiple sclerosis, head
injury or injury to the plexus.
- First of all, the nerve structures are built up
- then the functions are added on
- making use of new working principles
- confirmed by clinical studies
Why use the IMF® strategy?
In the case of neurogenic paralysis, by using the IMF® strategy you
will have the prospect of achieving more than "just" an improvement
in motor function. Even for those with the worst kind of handicap,
the IMF® strategy offers an improved quality of life for both the
patient and his or her relatives.
With conventional methods of healing neurogenic paralysis, there is a time window of about two years. After that time, the person affected is considered to be one for whom “all treatment options have failed”. In contrast to this, the IMF® strategy offers the user a perspective and a good prognosis, even after quite a few years of paralysis. For many of those who were affected and whom we have helped to achieve a significant improvement in motor function, this time window for commencing therapeutic measures had already passed.
Here are a few examples of success following treatment using the IMF® strategy with so-called “patients for whom all treatment options had failed”:
With conventional methods of healing neurogenic paralysis, there is a time window of about two years. After that time, the person affected is considered to be one for whom “all treatment options have failed”. In contrast to this, the IMF® strategy offers the user a perspective and a good prognosis, even after quite a few years of paralysis. For many of those who were affected and whom we have helped to achieve a significant improvement in motor function, this time window for commencing therapeutic measures had already passed.
Here are a few examples of success following treatment using the IMF® strategy with so-called “patients for whom all treatment options had failed”:
|
Indication |
Years of |
Success in |
|
|
|
|---|---|---|---|---|---|
|
Incomplete paraplegia (paraparesis) |
45 years |
able to move without aids |
|
|
|
|
Complete paraplegia (quadraplegia) |
32 years |
sitting function |
|
|
|
|
Stroke |
9 years |
complete hand function |
|
|
|
|
Stroke (6 re-infarcts) |
7 years |
complete hand function |
|
|
|
|
complete plexus paralysis |
25 years |
complete hand function |
|
|
|
|
|
|
|
|
|
|
These were confirmed by the results of studies
It was shown in a retrospective
control study that 17 out of 19 patients with the initial diagnosis
“complete paraplegia” were able to sit freely once more after
following the IMF® strategy for 7 months, which they were unable to
do before starting to apply the method. Indeed, of these, 7
patients were able once more to take up work again. None of the 13
patients in the control group were able to achieve this result. The
participants in this study were paralysed for 4.5 years, on
average, before the study started.
In a further study, in those individuals in whom a complete brachial nerve lesion could be established, it was shown that the quality of life of the 10 patients investigated had improved, as demonstrated by the fact that 9 out of 10 patients suffering from neurogenic pain were freed from pain. In 5 out of 10 patients, re-innervation was demonstrated in the upper extremity. This success was achieved already after a period of application of the IMF® strategy of 9 weeks. The duration of the illness (from the date of injury until the commencement of treatment) was, on average, 7.3 years.
In a further study, in those individuals in whom a complete brachial nerve lesion could be established, it was shown that the quality of life of the 10 patients investigated had improved, as demonstrated by the fact that 9 out of 10 patients suffering from neurogenic pain were freed from pain. In 5 out of 10 patients, re-innervation was demonstrated in the upper extremity. This success was achieved already after a period of application of the IMF® strategy of 9 weeks. The duration of the illness (from the date of injury until the commencement of treatment) was, on average, 7.3 years.